Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01466946 · ClinicalTrials.gov registry record
Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT01466946: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01466946 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01466946 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.
Primary Outcome
related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
Interventions
- BEHAVIORAL semi-structured interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-02 |
What the finished NCT01466946 record still lists
NCT01466946 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which semi-structured interviews is the first listed.
NCT01466946 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01466946 about?
NCT01466946 is a clinical study titled "Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients". The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.
What is the current status of trial NCT01466946?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2011-11. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01466946?
The interventions under investigation include: semi-structured interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT01466946?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia